Parkinsonism in cirrhosis: Pathogenesis and current therapeutic options

Metabolic Brain Disease

Volumn 28, Issue 2, 2013, Pages 261-267

  Butterworth, Roger F ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Acquired hepatolenticular degeneration akinesia; Basal ganglia; Bromocriptine; L DOPA; Liver transplantation; Magnetic resonance imaging; Parkinsonism in cirrhosis; Rigidity

Indexed keywords

BROMOCRIPTINE; DOPAMINE; EDETIC ACID; LEVODOPA; MANGANESE; PLACEBO; ANTIPARKINSON AGENT; CHELATING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT;

BASAL GANGLION; CHELATION THERAPY; CONFERENCE PAPER; DOPAMINE BRAIN LEVEL; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER TRANSPLANTATION; NEUROIMAGING; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PREVALENCE; SUBSTITUTION THERAPY; WILSON DISEASE; BRAIN LEVEL; COMPLICATION; HYPERAMMONEMIA; LIVER CIRRHOSIS; MANGANESE POISONING; PARKINSON DISEASE; PATHOLOGY; PHYSIOLOGY;

ANTIPARKINSON AGENTS; BRAIN CHEMISTRY; CHELATING AGENTS; DOPAMINE; DOPAMINE AGENTS; HUMANS; HYPERAMMONEMIA; LEVODOPA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MANGANESE POISONING; PARKINSON DISEASE;

EID: 84878019123     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-012-9341-7     Document Type: Conference Paper

References (37)

1. Bechar M, Freud M, Kott E, Kott I, Kravvic H, Stern J, Sandbank U, Bornstein B (1970) Hepatic cirrhosis with post-shunt myelopathy. J Neurol Sci 11(2):101-107
2. Bergeron M, Reader TA, Layrargues GP, Butterworth RF (1989) Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurochem Res 14(9):853-859
3. Burkhard PR, Delavelle J, Du Pasquier R, Spahr L (2003) Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration. Arch Neurol 60(4):521-528
4. Butterworth RF (2007) Neuronal cell death in hepatic encephalopathy. Metab Brain Dis 22(3-4):309-320
5. Butterworth RF (2012) Risk of falls in cirrhosis predicted by psychometric testing. Nature Reviews Gastroenterol Hepatol 9(4):197-198
6. Butterworth RF, Spahr L, Fontaine S, Layrargues GP (1995) Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy. Metab Brain Dis 10(4):259-267
7. de Bie RM, Gladstone RM, Strafella AP, Ko JH, Lang AE (2007) Manganese-induced Parkinsonism associated with methcathinone (Ephedrone) abuse. Arch Neurol 64(6):886-889
8. Fernández-Rodriguez R, Contreras A, De Villoria JG, Grandas F (2010) Acquired hepatocerebral degeneration: clinical characteristics and MRI findings. Eur J Neurol 17(12):1463-1470
9. Ferrara J, Jankovic J (2009) Acquired hepatocerebral degeneration. J Neurol 256(3):320-332
10. Finlayson MH, Superville B (1981) Distribution of cerebral lesions in acquired hepatocerebral degeneration. Brain 104(Pt 1):79-95
11. Huang CC, Chu NS, Lu CS, Wang JD, Tsai JL, Tzeng JL, Wolters EC, Calne DB (1989) Chronic manganese intoxication. Arch Neurol 46(10):1104-1106
12. Inoue E, Hori S, Narumi Y, Fujita M, Kuriyama K, Kadota T, Kuroda C (1991) Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images. Radiology 179(2):551-555
13. Klos KJ, Ahlskog JE, Josephs KA, Fealey RD, Cowl CT, Kumar N (2005) Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: probable manganese neurotoxicity. Arch Neurol 62(9):1385-1390
14. Kril JJ, Butterworth RF (1997) Diencephalic and cerebellar pathology in alcoholic and nonalcoholic patients with end-stage liver disease. Hepatology 26(4):837-841
15. Kril JJ, Flowers D, Butterworth RF (1997) Distinctive pattern of Bergmann glial pathology in human hepatic encephalopathy. Mol Chem Neuropathol 31(3):279-287
16. Lazeyras F, Spahr L, DuPasquier R, Delavelle J, Burkhard P, Hadengue A, Hochstrasser D, Mentha G, Giostra E, Terrier F, Vingerhoets F (2002) Persistence of mild parkinsonism 4 months after liver transplantation in patients with preoperative minimal hepatic encephalopathy: a study on neuroradiological and blood manganese changes. Transpl Int 15(4):188-195
17. Lunzer M, James IM, Weinman J, Sherlock S (1974) Treatment of chronic hepatic encephalopathy with levodopa. Gut 15(7):555-561
18. Michel H, Solere M, Granier P, Cauvet G, Bali JP, Pons F, Bellet-Hermann H (1980) Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial. Gastroenterology 79(2):207-211
19. Mirowitz SA, Westrich TJ, Hirsch JD (1991) Hyperintense basal ganglia on T1-weighted MR images in patients receiving parenteral nutrition. Radiology 181(1):117-120
20. Morgan MY, Jakobovits AW, James IM, Sherlock S (1980) Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology 78(4):663-670
21. Mousseau DD, Perney P, Layrargues GP, Butterworth RF (1993) Selective loss of pallidal dopamine D2 receptor density in hepatic encephalopathy. Neurosci Lett 162(1-2):192-196
22. Mousseau DD, Baker GB, Butterworth RF (1997) Increased density of catalytic sites and expression of brain monoamine oxidase A in humans with hepatic encephalopathy. J Neurochem 68(3):1200-1208
23. Park HK, Kim SM, Choi CG, Lee MC, Chung SJ (2008) Effect of trientine on manganese intoxication in a patient with acquired hepatocerebral degeneration. Mov Disord 23(5):768-770
24. Pinarbasi B, Kaymakoglu S, Matur Z, Akyuz F, Demir K, Besisik F, Ozdil S, Boztas G, Cakaloglu Y, Mungan Z, Okten A (2009) Are acquired hepatocerebral degeneration and hepatic myelopathy reversible? J Clin Gastroenterol 43(2):176-181
25. Pomier-Layrargues G (2001) Movement dysfunction and hepatic encephalopathy. Metab Brain Dis 16(1-2):27-35
26. Pomier-Layrargues G, Shapcott D, Spahr L, Butterworth RF (1995) Accumulation of manganese and copper in pallidum of cirrhotic patients: role in the pathogenesis of hepatic encephalopathy? Metab Brain Dis 10(4):353-356
27. Powell EE, Pender MP, Chalk JB, Parkin PJ, Strong R, Lynch S, Kerlin P, Cooksley WG, Cheng W, Powell LW (1990) Improvement in chronic hepatocerebral degeneration following liver transplantation. Gastroenterology 98(4):1079-1082
28. Rao VL, Giguère JF, Layrargues GP, Butterworth RF (1993) Increased activities of MAOA and MAOB in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Brain Res 621(2):349-352
29. Rose C, Butterworth RF, Zayed J, Normandin L, Todd K, Michalak A, Spahr L, Huet PM, Pomier-Layrargues G (1999) Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 117(3):640-644
30. Servin-Abad L, Tzakis A, Schiff ER, Regev A (2006) Acquired hepatocerebral degeneration in a patient with HCV cirrhosis: complete resolution with subsequent recurrence after liver transplantation. Liver Transpl 12(7):1161-1165
31. Shinotoh H, Snow BJ, Chu NS, Huang CC, Lu CS, Lee C, Takahashi H, Calne DB (1997) Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication: a positron emission tomography study. Neurology 48(4):1053-1056
32. Spahr L, Butterworth RF, Fontaine S, Bui L, Therrien G, Milette PC, Lebrun LH, Zayed J, Leblanc A, Pomier-Layrargues G (1996) Increased blood manganese in cirrhotic patients: relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. Hepatology 24(5):1116-1120
33. Spahr L, Vingerhoets F, Lazeyras F, Delavelle J, DuPasquier R, Giostra E, Mentha G, Terrier F, Hadengue A (2000) Magnetic resonance imaging and proton spectroscopic alterations correlate with parkinsonian signs in patients with cirrhosis. Gastroenterology 119(3):774-781
34. Stracciari A, Baldin E, Cretella L, Delaj L, D'Alessandro R, Guarino M (2011) Chronic acquired hepatocerebral degeneration: effects of liver transplantation on neurological manifestations. Neurol Sci 32(3):411-415
35. Uribe M, Farca A, Márquez MA, García-Ramos G, Guevara L (1979) Treatment of chronic portal systemic encephalopathy with bromocriptine: a double-blind controlled trial. Gastroenterology 76(6):1347-1351
36. Weissenborn K (2011) Parkinsonism in patients with cirrhosis: coincidence or consequence? Liver Int 31(5):592-594
37. Weissenborn K, Berding G, Köstler H (2000) Altered striatal dopamine D2 receptor density and dopamine transport in a patient with hepatic encephalopathy. Metab Brain Dis 15(3):173-178